Migayron et al. Front Immunol➜ DOI: 10.3389/fimmu.2024.1405215Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?This is an interesting review which approaches indirectly some of the paradoxical findings observed using targeted therapies in AD. Silverberg et al JAAD➜ DOI: 10.1016/j.jaad.2024.05.023Tapinarof Cream 1% Once Daily: Significant Efficacy in the Treatment of Moderate to Severe Atopic Dermatitis [...] Read More
We are proud to be a participating institution with World Health Organization on Global Initiative on AI for Skin Conditions! This WHO Neglected Tropical Diseases (NTD)-led Global Initiative discusses progress, challenges, gaps and solutions in developing and implementing artificial augmented intelligence-based apps as a capacity building and monitoring tool for skin NTDs and selected common skin conditions […]
Read More
Carmanius et al, JEADV 2024➜ DOI: 10.1111/jdv.20076A cross-sectional study based on the 24-year follow-up from the population-based birth cohort linked with dispensing data from the National Swedish Drug Register confirms that a large proportion of young adults with AD is undertreated or untreated. Kook et al, JEADV 2024➜ DOI: 10.1111/jdv.20053Misdiagnosis of AD or confounding skin diseases in [...] Read More
Organized by SOMADER May 22, 2024, Madagascar The ISAD is happy to participate to the next World Skin Health Day organized by the Malagasy Society of Dermatology (SOMADER) with a regional and global focus on AD challenges. This programme highlights also the new WHO policy around skin NTDs in low resource countries combined with the […]
Read More
May 11, 2024, Nouakchott, Mauritania ISAD Society President Alain TAÏEB visited Mauritania and met the members of the National Dermatology Society (SMD, President Prof BALL second rank right) on the occasion of very interesting meeting organized on May 11th jointly by the SMD and the Ministry of Health. Mariem KEBE (yellow, middle of second rank), […]
Read More
Federica Casetti, Cristina Has➜ First published: 03 March 2024 - DOI: 10.1111/ddg.15358Dupilumab improves congenital ichthyosis in the context of a filaggrin pathogenic variant. This report from Germany confirms other reports of a response of rare ichthyotic conditions such as Netherton’s syndrome and trichothiodystrophy to targeting IL-4Rα, and that the common FLG mutations may accentuate the inflammatory phenotype [...] Read More
Docampo-Simon et al Int J Dermatol 2024➜ First published: 03 March 2024 - DOI: 10.1111/ijd.17100Spanish investigators delineate based on a small case series psoriasis dermatitis, a common ambiguous phenotype of early forms of both psoriasis and atopic dermatitis in children; this phenotype was already well recognized in infants, but this study adds arguments for a later [...] Read More
Omatsu et al, Allergol Int 2024➜ PMID: 38310042. - DOI: 10.1016/j.alit.2024.01.008An interesting study from Japan shows that AD is very significantly associated with the incidence of HSV keratitis, and that preexisting AD blepharitis is an important contributing factor.This paper is important in the context of real or supposed AD co-morbidities where ophthalmologic comorbidities are generally not adequately [...] Read More
On July 3rd at the Singapore WCD, we discussed “Global Aspects of AD” with an international expert panel and an audience representative of the diversity of our field. A derived JEADV position paper “AD: A Global Health Perspective” is now published. The Singapore roundtable was an opportunity to compare experiences in World Bank category 1 […]
Read More
Communication from the LEO Foundation: The Global Atopic Dermatitis Atlas (GADA), a pioneering international initiative dedicated to advancing our understanding of Atopic Dermatitis (AD), is thrilled to announce DKK 10 million grant funding support from the LEO Foundation, forming an important strategic collaboration with leading organisations: the International League of Dermatological Societies (ILDS) and collaborating […]
Read More